MD Anderson Cancer Center

Member

MD Anderson Cancer Center's Articles

MD Anderson Cancer Center's articles RSS

Page 3 of 70

Distinct immune signature predicts progression of vestibular schwannoma and unveils a possible viral etiology

Authors: Moran Amit, Tongxin Xie, Frederico O. Gleber-Netto, Patrick J. Hunt, Gautam U. Mehta, Diana Bell, Deborah A. Silverman, Ismail Yaman, Yi Ye, Jared K. Burks, Gregory N. Fuller, Paul W. Gidley, Marc-Elie Nader, Shaan M. Raza and Franco DeMonte

Citation: Journal of Experimental & Clinical Cancer Research 2022 41:292

Content type: Research Published on: 4 October 2022
Exploring patient experiences with a telehealth approach for the PRO-ACTIVE trial intervention in head and neck cancer patients

Authors: M. M. Khan, B. Manduchi, V. Rodriguez, M. I. Fitch, C. E. A. Barbon, H. McMillan, K. A. Hutcheson and R. Martino

Citation: BMC Health Services Research 2022 22:1218

Content type: Research article Published on: 30 September 2022
TIGIT is the central player in T-cell suppression associated with CAR T-cell relapse in mantle cell lymphoma

Authors: Vivian Changying Jiang, Dapeng Hao, Preetesh Jain, Yijing Li, Qingsong Cai, Yixin Yao, Lei Nie, Yang Liu, Jingling Jin, Wei Wang, Heng-Huan Lee, Yuxuan Che, Enyu Dai, Guangchun Han, Ruiping Wang, Kunal Rai…

Citation: Molecular Cancer 2022 21:185

Content type: Research Published on: 26 September 2022
The ABNL-MARRO 001 study: a phase 1–2 study of randomly allocated active myeloid target compound combinations in MDS/MPN overlap syndromes

Authors: Tamara K. Moyo, Jason H. Mendler, Raphael Itzykson, Ashwin Kishtagari, Eric Solary, Adam C. Seegmiller, Aaron T. Gerds, Gregory D. Ayers, Amy E. Dezern, Aziz Nazha, Peter Valent, Arjan A. van de Loosdrecht, Francesco Onida, Lisa Pleyer, Blanca Xicoy Cirici, Raoul Tibes…

Citation: BMC Cancer 2022 22:1013

Content type: Study protocol Published on: 24 September 2022
Systematic endoscopic staging of mediastinum to determine impact on radiotherapy for locally advanced lung cancer (SEISMIC): protocol for a prospective single arm multicentre interventional study

Authors: Daniel P. Steinfort, Shankar Siva, Kanishka Rangamuwa, Percy Lee, David Fielding, Phan Nguyen, Barton R. Jennings, Shaun Yo, Nick Hardcastle, Gargi Kothari, Laurence Crombag, Jouke Annema, Kazuhiro Yasufuku, David E. Ost and Louis B. Irving

Citation: BMC Pulmonary Medicine 2022 22:364

Content type: Study protocol Published on: 24 September 2022
Combining a nanoparticle-mediated immunoradiotherapy with dual blockade of LAG3 and TIGIT improves the treatment efficacy in anti-PD1 resistant lung cancer

Authors: Yun Hu, Sébastien Paris, Genevieve Bertolet, Hampartsoum B. Barsoumian, Kewen He, Duygu Sezen, Dawei Chen, Mark Wasley, Jordan DA SILVA, Joylise A. Mitchell, Tiffany A. Voss, Fatemeh Masrorpour, Claudia Kettlun Leyton, Liangpeng Yang, Carola Leuschner, Nahum Puebla-Osorio…

Citation: Journal of Nanobiotechnology 2022 20:417

Content type: Research Published on: 19 September 2022
Association between abnormal lipid profile and inflammation and progression of myelodysplastic syndrome to acute leukemia

Authors: Wei Qiao, Elliana Young, Chun Feng, Suyu Liu, Jeff Jin, Laila Noor, Cristhiam M. Rojas Hernandez, Gautam Borthakur, Olga Gorlova and Vahid Afshar-Kharghan

Citation: Experimental Hematology & Oncology 2022 11:58

Content type: Correspondence Published on: 16 September 2022
Can statins lessen the burden of virus mediated cancers?

Authors: Eva H. Clark, Sarah T. Ahmed, Elaine Chang, Elizabeth Y. Chiao and Donna L. White

Citation: Infectious Agents and Cancer 2022 17:47

Content type: Comment Published on: 4 September 2022
Metagenomes of rectal swabs in larger, advanced stage cervical cancers have enhanced mucus degrading functionalities and distinct taxonomic structure

Authors: Tatiana V. Karpinets, Xiaogang Wu, Travis Solley, Molly B. El Alam, Travis T. Sims, Kyoko Yoshida-Court, Erica Lynn, Mustapha Ahmed-Kaddar, Greyson Biegert, Jingyan Yue, Xingzhi Song, Huandong Sun, Joseph F. Petrosino, Melissa P. Mezzari, Pablo Okhuysen, Patricia J. Eifel…

Citation: BMC Cancer 2022 22:945

Content type: Research article Published on: 1 September 2022
GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinoma

Authors: Yuan Li, Yibo Fan, Jinbang Xu, Longfei Huo, Ailing W. Scott, Jiankang Jin, Boxuan Yang, Shan Shao, Lang Ma, Ying Wang, Xiaodan Yao, Melissa Pool Pizzi, Matheus Sewastjanow Da Silva, Guoliang Zhang, Lijuan Zhuo, Eun Jeong Cho…

Citation: Journal of Experimental & Clinical Cancer Research 2022 41:257

Content type: Research Published on: 23 August 2022
Effect of therapeutic versus prophylactic anticoagulation therapy on clinical outcomes in COVID-19 patients: a systematic review with an updated meta-analysis

Authors: Hong Duo, Yahui Li, Yujie Sun, Liang Wei, Ziqing Wang, Fang Fang, Yuxin Zhong, Jiao Huang, Linjie Luo, Zhiyong Peng and Huaqin Pan

Citation: Thrombosis Journal 2022 20:47

Content type: Research Published on: 23 August 2022
Sensory neuron dysfunction in orthotopic mouse models of colon cancer

Authors: Mihály Balogh, Jixiang Zhang, Caitlyn M. Gaffney, Neha Kalakuntla, Nicholas T. Nguyen, Ronnie T. Trinh, Clarissa Aguilar, Hoang Vu Pham, Bojana Milutinovic, James M. Nichols, Rajasekaran Mahalingam and Andrew J. Shepherd

Citation: Journal of Neuroinflammation 2022 19:204

Content type: Research Published on: 12 August 2022
Ryanodine receptor 1-mediated Ca²⁺ signaling and mitochondrial reprogramming modulate uterine serous cancer malignant phenotypes

Authors: Li Zhang, Chi-Lam Au-Yeung, Chunxian Huang, Tsz-Lun Yeung, Sammy Ferri-Borgogno, Barrett C. Lawson, Suet-Ying Kwan, Zheng Yin, Stephen T. Wong, Vienna Thomas, Karen H. Lu, Kay-Pong Yip, James S. K. Sham and Samuel C. Mok

Citation: Journal of Experimental & Clinical Cancer Research 2022 41:242

Content type: Research Published on: 11 August 2022
Correction: Innate immune mediator, Interleukin-1 receptor accessory protein (IL1RAP), is expressed and pro-tumorigenic in pancreatic cancer

Authors: Yang Zhang, Xiaoyi Chen, Huamin Wang, Shanisha Gordon-Mitchell, Srabani Sahu, Tushar D. Bhagat, Gaurav Choudhary, Srinivas Aluri, Kith Pradhan, Plabani Sahu, Milagros Carbajal, Hui Zhang, Beamon Agarwal, Aditi Shastri, Robert Martell, Daniel Starczynowski…

Citation: Journal of Hematology & Oncology 2022 15:100

Content type: Correction Published on: 26 July 2022

The original article was published in Journal of Hematology & Oncology 2022 15:70
Cardiovascular adverse events in oncology trials: understanding and appreciating the differences between clinical trial data and real-world reports

Authors: Michael S. Ewer and Jay Herson

Citation: Cardio-Oncology 2022 8:13

Content type: Review Published on: 19 July 2022
A clinician perspective on the treatment of chronic myeloid leukemia in the chronic phase

Authors: Valentin García-Gutiérrez, Massimo Breccia, Elias Jabbour, Michael Mauro and Jorge E. Cortes

Citation: Journal of Hematology & Oncology 2022 15:90

Content type: Review Published on: 11 July 2022
Aberrant DNA hydroxymethylation reshapes transcription factor binding in myeloid neoplasms

Authors: Jia Li, Tingting Hong, Yue Wei, Lei Guo, Minjung Lee, Hui Yang, Caleb Class, Yaling Yang, Xiaoqiong Wang, Hua He, Stefan Siwko, M. James You, Yubin Zhou, Guillermo Garcia-Manero and Yun Huang

Citation: Clinical Epigenetics 2022 14:81

Content type: Research Published on: 28 June 2022
Incidental irradiation of the regional lymph nodes during deep inspiration breath-hold radiation therapy in left-sided breast cancer patients: a dosimetric analysis

Authors: Jule Wolf, Steffen Kurz, Thomas Rothe, Marco Serpa, Jutta Scholber, Thalia Erbes, Eleni Gkika, Dimos Baltas, Vivek Verma, David Krug, Ingolf Juhasz-Böss, Anca-Ligia Grosu, Nils H. Nicolay and Tanja Sprave

Citation: BMC Cancer 2022 22:682

Content type: Research Published on: 21 June 2022
Neoadjuvant immunotherapy across cancers: meeting report from the Immunotherapy Bridge—December 1st–2nd, 2021

Authors: Elizabeth M. Burton, Rodabe N. Amaria, Tina Cascone, Myriam Chalabi, Neil D. Gross, Elizabeth A. Mittendorf, Richard A. Scolyer, Padmanee Sharma and Paolo A. Ascierto

Citation: Journal of Translational Medicine 2022 20:271

Content type: Meeting report Published on: 15 June 2022
A first-in-human phase 1/2 study of FGF401 and combination of FGF401 with spartalizumab in patients with hepatocellular carcinoma or biomarker-selected solid tumors

Authors: Stephen L. Chan, Martin Schuler, Yoon-Koo Kang, Chia-Jui Yen, Julien Edeline, Su Pin Choo, Chia-Chi Lin, Takuji Okusaka, Karl-Heinz Weiss, Teresa Macarulla, Stéphane Cattan, Jean-Frederic Blanc, Kyung-Hun Lee, Michela Maur, Shubham Pant, Masatoshi Kudo…

Citation: Journal of Experimental & Clinical Cancer Research 2022 41:189

Content type: Research Published on: 2 June 2022